Asahi Kasei To Further Expand Kidney Dialyzers Market
This article was originally published in PharmAsia News
Executive Summary
Ranked second worldwide in polysulfone dialysis products, Asahi Kasei Medical plans to further invest and expand the market for its core products APS dialyzers in 2009. With a strong yen, Asahi Kuraray Medical plans to establish overseas manufacturing bases and innovative product designs to lower production costs. With a dwindling domestic market, the company also looks to expand markets in Europe, the U.S. and emerging countries. It already started product assembly in China, and licensed technology to a Thailand factory. The company's German subsidiary Asahi Kasei Europe will distribute products to sales agents in each European country. (Click here for more - Japanese language
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.